Hepatitis C vaccine
A next-generation hepatitis C vaccine that combines viral vector technologies and optimized antigen design to
induce broad, functional T cell responses across diverse HCV genotypes. The antigen is designed as a recombinant
polypeptide and can be delivered through peptide, nucleic acid, or viral-vector formats, supporting broad-spectrum
prophylactic and therapeutic vaccination strategies.
Applications: Vaccines, Hepatitis C
| Features | Benefits |
|---|---|
| Pan-genotypic antigen design targeting HCV genotypes 1-6 | Addresses challenges posed by viral genetic diversity |
| Conserved-region immunogen engineering | Expands immune recognition across diverse HCV strains |
| Suitable for viral vector or nucleic acid deliver approaches | Flexible vaccine development pathways |
| Induces broad CD4+ and CD8+ T cell responses | Enhances T cell cross-reactivity between genotypes and durable cellular immunity |
Patented and Available For
- Co-development
- Consulting
- Licensing